DarioHealth董事Lawrence Leisure因个人原因退休且无分歧

----- tm2624391d1_8k.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date
of Earliest Event Reported):
September 2, 2026
DARIOHEALTH CORP.
(Exact name of registrant as specified in its charter)
Delaware
001-37704
45-2973162
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
322
W. 57th St.
,
#33B
New York
,
New
York
10019
(Address of Principal Executive Offices)
972
-
4-770-6377
(Issuer’s telephone
number)
(Former name or former
address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
Trading
Symbol(s)
Name of exchange on which
registered
Common Stock, par value $0.0001 per share
DRIO
The
Nasdaq
Capital Market LLC
Indicate by check mark whether the registrant is an emerging growth
company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company
¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 2, 2026, Lawrence
Leisure notified the Board of Directors (the “Board”) of DarioHealth Corp. (the “Company”) of his decision to
retire from the Board, effective September 2, 2026, for personal reasons. Mr. Leisure’s decision to retire was not the result of
any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: September 4, 2026
DARIOHEALTH CORP.
By:
/s/ Chen Franco-Yehuda
Name:
Chen Franco-Yehuda
Title:
Chief Financial Officer, Treasurer and Secretary